FAKTOR OPTIONSSCHEIN - ASTRAZENECA ADR | Market Closed - Börse Stuttgart 02:18:47 26/06/2024 pm IST | ||
| 7.01 EUR | -3.18% |
|
| Current month | -11.04% | ||
| 1 month | -8.13% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 7.01 | -3.18% |
| 25/24/25 | 7.24 | -2.56% |
| 24/24/24 | 7.43 | -1.46% |
| 21/24/21 | 7.54 | +0.67% |
| 20/24/20 | 7.49 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 02:18 pm IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | UBS |
| WKN | UM5DPA |
| ISIN | DE000UM5DPA0 |
| Date issued | 14/05/2024 |
| Strike | 106.3 $ |
| Maturity | Unlimited |
| Parity | 3.43 : 1 |
| Emission price | 8 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.18 € |
|---|---|
| Lowest since issue | 6.8 € |
| Spread | 0.03 € |
| Spread % | 0.40% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
158.5
USD
Average target price
174.4
USD
Spread / Average Target
+10.04%
- Stock Market
- Certificates
- Certificat
